Platten, M., Schilling, D., Bunse, L., Wick, A., Bunse, T., Riehl, D., Green, E., Sanghvi, K., Karapanagiotou-Schenkel, I., Harting, I., Sahm, F., Steinbach, J., Weyerbrock, A., Hense, J., Misch, M., Krex, D., Setvanovic, S., Tabatabai, G., von Deimling, A., Schmitt, M., & Wick, W. (n.d.). oS6.4 NOA-16: A first-in-man multicenter phase I clinical trial of the German Neurooncology Working Group evaluating a mutation-specific peptide vaccine targeting IDH1R132H in patients with newly diagnosed malignant astrocytomas. Neuro-oncology, 20, iii226–iii227. http://access.bl.uk/ark:/81055/vdc_100095514174.0x000016